2-[(2R)-pyrrolidin-2-ylmethoxy]pyridine | 1032049-11-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-[(2R)-pyrrolidin-2-ylmethoxy]pyridine
• 英文别名: 2-[[(2R)-pyrrolidin-2-yl]methoxy]pyridine
• CAS: 1032049-11-8
• 化学式: C₁₀H₁₄N₂O
• 分子量: 178.234
• InChiKey: GCSIIAQHFHXSCJ-SECBINFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  34.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-[(2R)-pyrrolidin-2-ylmethoxy]pyridine 、 1-环丙基-6,7-二氟-5-甲基-4-氧代-3-喹啉羧酸 以 二甲基亚砜 为溶剂， 反应 1.0h， 以11.6 mg的产率得到1-cyclopropyl-6-fluoro-5-methyl-4-oxo-7-[(2R)-2-[(pyridin-2-yloxy)methyl]pyrrolidin-1-yl] quinoline-3-carboxylic acid
  参考文献：
  名称：

  [EN] COMPOUNDS TARGETING RNA-BINDING PROTEINS OR RNA-MODIFYING PROTEINS
  [FR] COMPOSÉS CIBLANT DES PROTÉINES DE LIAISON À L'ARN OU DES PROTÉINES MODIFIANT L'ARN

  摘要：

  该发明涉及由化学式（I）表示的化合物，或其药用可接受盐，包括含有该化合物的组合物以及制备和使用该化合物的方法。这里描述了变量。

  公开号：

  WO2021178420A1

文献信息

• [EN] ENANTIONSELECTIVE PROCESSES TO INSECTICIDAL 3-ARYL-3-TRIFLUOROMETHYL-SUBSTITUTED PYRROLIDINES<br/>[FR] PROCÉDÉS ÉNANTIOSÉLECTIFS POUR DES INSECTICIDES DE PYRROLIDINES 3-ARYL-3-TRIFLUOROMÉTHYL-SUBSTITUÉES
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：WO2013050301A1

  公开（公告）日：2013-04-11

  The present invention relates to processes for the enantio-selective preparation of spyrrolidine derivatives useful in the manufacture of pesticidally active compounds, as well as to intermedates in the processes. The processes include those comprising (a-i) reacting a compound of formula (Ia), formula (Ia), wherein P is alkyl, aryl or heteroaryl, each optionally substituted, wherein the heteroaryl is connected at P via a ring carbon atom; R1 is chlorodifluoromethyl or trifluoromethyl; R2 is aryl or heteroaryl, each optionally substituted; with a source of cyanide in the presence a chiral catalyst to give a compound of formula IIa, formula (IIa), wherein P, R1 and R2 are as defined for the compound of formula (Ia); and (a-ii) oxidising the compound of formula IIa with a peroxy acid, or peroxide in the presence of an acid to give a compound of formula (VI), formula (VI), wherein R1 and R2 are as defined for the compound of formula (Ia).

  本发明涉及用于对手性选择性地制备在制造具有杀虫活性化合物中有用的吡咯烷衍生物的过程，以及在这些过程中的中间体。这些过程包括以下步骤：(a-i)将式(Ia)的化合物与氰化物源在手性催化剂存在下反应，其中式(Ia)中，P为烷基、芳基或杂芳基，每个都可以选择性地取代，其中杂芳基通过一个环碳原子连接到P；R1为氯二氟甲基或三氟甲基；R2为芳基或杂芳基，每个都可以选择性地取代，以得到式(IIa)的化合物，其中P、R1和R2如式(Ia)的化合物所定义；(a-ii)将式IIa的化合物与过氧酸或过氧化物在酸存在下氧化，以得到式(VI)的化合物，其中R1和R2如式(Ia)的化合物所定义。
• [EN] HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION<br/>[FR] COMPOSES ETHER ET THIOETHER HETEROCYCLIQUES UTILISES DANS LA REGULATION DE LA TRANSMISSION SYNAPTIQUE CHIMIQUE
  申请人：ABBOTT LABORATORIES

  公开号：WO1999032480A1

  公开（公告）日：1999-07-01

  (EN) Novel compounds having formulas (I), (II) or (III) or pharmaceutically-acceptable salts or prodrugs thereof, which are useful for controlling synaptic transmission; to therapeutically-effective pharmaceutical compositions of these compounds; and to the use of said compositions to controlling synaptic transmission in human or veterinary patients.(FR) L'invention porte sur de nouveaux composés ayant les formules (I), (II) ou (III), ou sur leurs sels pharmaceutiquement acceptables ou promédicaments, et qui sont utilisés dans la régulation de la transmission synaptique. L'invention porte également sur les compositions pharmaceutiques thérapeutiquement efficaces de ces composés, et sur l'utilisation de ces compositions pour réguler la transmission synaptique chez l'homme ou l'animal.

  （中文翻译）本发明涉及具有公式（I），（II）或（III）或其药学上可接受的盐或前药的新化合物，其用于控制突触传递；以及这些化合物的治疗有效的药物组合物，以及使用该组合物在人类或兽医患者中控制突触传递的用途。
• PROCESSES FOR THE PREPARATION OF PYRROLIDINE INTERMEDIATES
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：US20140296527A1

  公开（公告）日：2014-10-02

  The present invention relates to processes for the enantio-selective preparation of spyrrolidine derivatives useful in the manufacture of pesticidally active compounds, as well as to intermediates in the processes. The processes include those comprising (a-i) reacting a compound of formula Ia wherein P is alkyl, aryl or heteroaryl, each optionally substituted, wherein the heteroaryl is connected at P via a ring carbon atom; R 1 is chlorodifluoromethyl or trifluoromethyl; R 2 is aryl or heteroaryl, each optionally substituted; with a source of cyanide in the presence a chiral catalyst to give a compound of formula IIa wherein P, R 1 and R 2 are as defined for the compound of formula Ia; and (a-ii) oxidising the compound of formula IIa with a peroxy acid, or peroxide in the presence of an acid to give a compound of formula VI wherein R 1 and R 2 are as defined for the compound of formula Ia.

  本发明涉及用于手性选择性制备spyrrolidine衍生物的过程，该衍生物在制造杀虫活性化合物方面有用，以及该过程中的中间体。该过程包括以下步骤：(a-i)将式Ia化合物与氰化物源在手性催化剂的存在下反应，其中式Ia化合物中，P为烷基、芳基或杂环芳基，每个可选地被取代，其中杂环芳基通过环碳原子连接到P；R1为氯二氟甲基或三氟甲基；R2为芳基或杂环芳基，每个可选地被取代，以给出式IIa化合物，其中P、R1和R2与式Ia化合物中的定义相同；以及(a-ii)在酸的存在下，将式IIa化合物与过氧酸或过氧化物氧化，以给出式VI化合物，其中R1和R2与式Ia化合物中的定义相同。
• <i>N</i>-[6-Amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A_2A Receptor Antagonists with Improved Drug Like Properties and in Vivo Efficacy
  作者：Marion C. Lanier、Manisha Moorjani、Zhiyong Luo、Yongsheng Chen、Emily Lin、John E. Tellew、Xiaohu Zhang、John P. Williams、Raymond S. Gross、Sandra M. Lechner、Stacy Markison、Tanya Joswig、William Kargo、Jaime Piercey、Mark Santos、Siobhan Malany、Marilyn Zhao、Robert Petroski、María I. Crespo、José-Luis Díaz、John Saunders、Jenny Wen、Zhihong O’Brien、Kayvon Jalali、Ajay Madan、Deborah H. Slee

  DOI：10.1021/jm800908d

  日期：2009.2.12

  In the present article, we report on a strategy to improve the physical properties of a series of small molecule human adenosine 2A (hA(2A)) antagonists. One of the aromatic rings typical of this series of antagonists is replaced with a series of aliphatic groups, with the aim of disrupting crystal packing of the molecule to lower the melting point and in turn to improve the solubility. Herein, we describe the SAR of a new series of water-soluble 2,4,6-trisubstituted pyrimidines where R-1 is an aromatic heterocycle, R-2 is a short-chain alkyl amide, and the typical R-3 aromatic heterocyclic substituent is replaced with an aliphatic amino substituent. This approach significantly enhanced aqueous solubility and lowered the log P of the system to provide molecules without significant hERG or CYP liabilities and robust in vivo efficacy.
• HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION
  申请人：Abbott Laboratories

  公开号：EP1047690A1

  公开（公告）日：2000-11-02